Cramer Rosenthal McGlynn’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
NAMI
Cramer Rosenthal McGlynn's OMCL Position: Q2 2026 in Review
Cramer Rosenthal McGlynn reduced its Omnicell (OMCL) stake by 1.6% in Q2 2026, selling an estimated $195K and leaving 298,597 shares worth $12.4M. The position accounts for 0.63% of the portfolio, ranked #52.
Cramer Rosenthal McGlynn first reported a position in OMCL in Q2 2016 and has held it in 19 quarters since. The position peaked at $63.1M in Q1 2018. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.
- Cramer Rosenthal McGlynn held 298,597 shares of Omnicell worth $12.4M as of Q2 2026.
- Cramer Rosenthal McGlynn sold 4,834 Omnicell shares in Q2 2026, an estimated $195K.
- Omnicell made up 0.63% of Cramer Rosenthal McGlynn's portfolio in Q2 2026, its #52 holding.
- Cramer Rosenthal McGlynn first reported a position in Omnicell in Q2 2016 and has held it in 19 quarters since.
- Cramer Rosenthal McGlynn's Omnicell position peaked at $63.1M in Q1 2018.
- 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.
Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2026, filed 13 Aug 2026.